BioStem Technologies, Inc.
BSEM
$3.71
-$0.25-6.22%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.82M | 761.10K | -564.40K | -564.40K | 3.91M |
| Total Depreciation and Amortization | 592.30K | 114.70K | 90.20K | 90.20K | 78.10K |
| Total Amortization of Deferred Charges | -- | 0.00 | 25.40K | 25.40K | 38.20K |
| Total Other Non-Cash Items | 1.55M | 1.44M | 2.39M | 2.39M | 1.96M |
| Change in Net Operating Assets | 5.85M | -4.70M | 3.48M | 3.48M | -1.91M |
| Cash from Operations | -825.50K | -2.38M | 5.42M | 5.42M | 4.07M |
| Capital Expenditure | -1.80K | -2.42M | -332.40K | -332.40K | -164.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -15.02M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 1.25M | -- | -- | -- |
| Cash from Investing | -15.02M | -1.17M | -332.40K | -332.40K | -164.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -150.00K | -919.60K | -919.60K | -101.80K |
| Issuance of Common Stock | -- | 15.00K | 0.00 | 0.00 | 33.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -135.00K | -919.60K | -919.60K | -68.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.85M | -3.69M | 4.17M | 4.17M | 3.84M |